Quotes 5-day view Delayed Nasdaq
1 213 326
436 710 Volume
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohnâ€™s disease, ulcerative colitis, lupus and other viral diseases. The Companyâ€™s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product...
Ratings of Provention Bio, Inc.
All news about PROVENTION BIO, INC.
09/16 PROVENTION BIO : to Present at the Oppenheimer Fall Healthcare Life Sciences and..
09/13 Provention Bio, Inc. Provides Update on the Potential Timing of Teplizumab At..
08/06 PROVENTION BIO : Oppenheimer Adjusts Provention Bio PT to $16 From $18, Maintain..
08/05 PROVENTION BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
08/05 PROVENTION BIO, INC. : Results of Operations and Financial Condition, Financial ..
08/05 PROVENTION BIO : Earnings Flash (PRVB) PROVENTION BIO Posts Q2 Loss $-0.46, vs. ..
08/05 PROVENTION BIO : Reports Second Quarter 2021 Financial Results and Provides Busi..
08/05 Provention Bio, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
07/29 PROVENTION BIO : to Report Second Quarter 2021 Financial Results on August 5, 20..
07/19 PROVENTION BIO : Levi & Korsinsky, LLP
07/19 PRVB FINAL DEADLINE : Bronstein, Gewirtz & Grossman, LLC Reminds Provention Bio,..
07/18 SHAREHOLDER ALERT : Pomerantz Law Firm Reminds Shareholders with Losses on their..
07/16 FINAL DEADLINE : ROSEN, A RANKED AND LEADING FIRM, Encourages Provention Bio, In..
07/16 THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the ..
07/15 GLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class..
News in other languages on PROVENTION BIO, INC.
- No features available -
Analyst Recommendations on PROVENTION BIO, INC.
Chart PROVENTION BIO, INC.
Technical analysis trends PROVENTION BIO, INC.
Short Term Mid-Term Long Term Trends Bullish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target